Fusion Antibodies has worked with many pharmaceutical companies, universities and government agencies around the globe.
Our world class, reliable, professional contract research services allow these companies to speed up their drug development processes, optimise their expression protocols and discover their antibody sequences.
Fusion Antibodies have entered into a partnership with Swiss contract manufacturing organisation Celonic AG to collaborate on the development of high yield stable cell lines. The deal will allow clients of Fusion Antibodies a direct & efficient supply path to clinical trial material by taking advantage of the scale-up and development capabilities of Celonic.
Celonic is a CDMO/CMO based in Basel, Switzerland offering clients the development and manufacturing services for New Biological Enities (NBEs) and Biosimilars worldwide. The services include the development of cell lines, production processes as well as the GMP and non-GMP manufacturing of biopharmaceutical drug substances. In addition Celonic licenses its proprietary SEFEX cell line technology to clients, drug developers and other service provider.
Visit Celonic's website at www.celonic.com.
Fusion Antibodies have been collaborating with C-Term Diagnistics for over 5 years and have developed a bladder cancer ELISA kit for detection of the unphosphorylated and TFSTP-Pser258 isoforms of Tissue Factor Signal Transduction Peptide in unfractionated and fractionated urine samples. The detection assay is currently going through CE marking and substantial clinical trials in the UK coordinated by Fusion Antibodies. IVD kits are in development and lateral flow and other formats are in early stage development also. Trials already performed have established 90% sensitivity and specificity.
Of particular note is the tests capability of detecting early stage Bladder Cancer with great accuracy.
Visit C-Term's website at www.ctermdiagnostics.com.
BizCom Japan, Inc. is a trading and consulting company based in Tokyo, Japan. From its foundation in 1996, it has been collaborating with various innovative companies in biotechnology, pharmaceutical, diagnostic, cosmetic and medical device industries. In addition to providing research reagents, services and equipment to the life science researchers, BizCom Japan gives personalized solutions to its clients.
BizCom Japan act as Fusion Antibodies distributor to the Japanese market.
More information is available at http://www.bizcomjapan.com/
Feel free to get in touch for any further information. We would love to hear from you.Contact Us